Voxtur
Bio Limited, is an unlisted public company incorporated on 06 December, 2012.
It is classified as a public limited company and is located in , Maharashtra.
It's authorized share capital is INR 6.50 cr and the total paid-up capital is
INR 6.37 cr.
Voxtur
Bio Limited manufactures in-vitro diagnostic (IVD) kits, reagents, and medical
consumables for clinical laboratories and point-of-care testing. Their products
help diagnose various diseases, including infectious diseases like HIV and HCV,
as well as other conditions like sickle cell disease. The company emphasizes
in-house research and development to create high-quality, affordable diagnostic
solutions, and its facilities are FDA licensed and accredited to meet standards
like GMP and ISO 9001/13485.
|
Voxtur Bio Limited Outstanding Shares: |
63,71,032 |
|
Face Value of Voxtur Bio Share |
Rs. 10/- Per Equity Share |
|
ISIN of Voxtur Bio Limited Share |
INE149W01011 |
|
Lot Size of Voxtur Bio Share |
100 |
|
Voxtur Bio Share Price |
Best In Industry |
|
PAN Number of Voxtur Bio |
AAECV2679R |
|
GST Number of Voxtur Bio |
27AAECV2679R1ZD |
|
Voxtur Bio Limited CIN Number |
U25190MH2012PLC238544 |
|
Voxtur Bio Limited Registration Date |
06 Dec 2012 |
|
Category / Sub-Category of Voxtur Bio Limited |
Company limited by
shares/Non-Govt Company |
|
Voxtur Bio Limited Registered Office Address |
Plot No. A-1, Royal
Compound, Vill. Kaman Tamanmal Kaman Bhiwandi Road, Thane, Taluka Vasai,
Maharashtra, India, 401208 |
|
Voxtur Bio Limited Registrar & Transfer Agent
Address |
Mufg Intime India Private Limited |
|
Directors |
Post |
|
Veeraal
Ramesh Gandhi |
Managing
Director |
|
Nikhil
Dilipbhai Bhuta |
Director |
|
Rajasekhar
Bhaskeran Nair |
Director |
|
Name and Description of main products/services |
NIC Code of the product/service* |
% to the total turnover of the Company |
|
Manufacture of other medical and surgical equipment and orthopaedic appliances, n.e.c. |
33119 |
100% |
|
Company Name |
Subsidiary/Associate/Joint Venture |
Stake % |
|
Microzion Laboratories Private Limited |
Wholly Owned Subsidiary |
100% |
|
Vitrokits
Private Limited |
Wholly Owned Subsidiary |
100% |
Category | No. of Shares | % of Shares held |
Promoters |
|
|
Public Shareholding |
|
|
Total |
| 100.00% |
Q: What
is the face value of Voxtur Bio Ltd shares?
Answer: The face value of Voxtur Bio Ltd is ₹10 per equity share.
Q: What
is the minimum lot size for buying Voxtur Bio shares through WWIPL?
Answer: The minimum investment lot for Voxtur Bio is 100 equity
shares.
Q: How
can I buy Voxtur Bio unlisted shares through WWIPL?
Answer: Investors can complete their KYC, confirm the transaction with
WWIPL, transfer funds, and receive the shares directly in their Demat account.
Q: Why
should I buy Voxtur Bio shares through WWIPL?
Answer: WWIPL offers transparent pricing, secure transactions, fast
Demat transfers, and end-to-end support throughout the unlisted share
investment process.
Q: Is
investing in Voxtur Bio Ltd a good idea?
Answer: Investors typically evaluate Voxtur Bio based on its presence in
the in-vitro diagnostics (IVD) industry, in-house R&D capabilities, product
portfolio, and long-term opportunities in India's healthcare diagnostics
market.
Q: Why do
investors buy Voxtur Bio shares before a potential IPO?
Answer: Investors seek early exposure to a healthcare diagnostics
company before a potential listing, aiming to participate in future value
creation and liquidity opportunities.
Q: What
business does Voxtur Bio Ltd operate in?
Answer: Voxtur Bio manufactures in-vitro diagnostic (IVD) kits,
reagents, and medical consumables used by clinical laboratories and
point-of-care testing facilities.
Q: What
makes Voxtur Bio different from other unlisted healthcare companies?
Answer: The company focuses on indigenous R&D, affordable diagnostic
solutions, and operates manufacturing facilities compliant with GMP, ISO
standards, and FDA licensing requirements.
Q: What
are the key growth drivers for Voxtur Bio Ltd?
Answer: Increasing demand for diagnostic testing, expansion of
preventive healthcare, product innovation, export opportunities, and growth in
the IVD market are key growth drivers.
Q: What
factors affect the valuation of Voxtur Bio shares?
Answer: Revenue growth, profitability, product approvals, manufacturing
capacity, R&D investments, and expansion into domestic and international
markets influence the company's
valuation.
Q: Are
Voxtur Bio shares available in Demat form?
Answer: Yes. Shares purchased through WWIPL are transferred directly to
the investor's Demat account.
Q: Can I
sell my Voxtur Bio shares through WWIPL?
Answer: Yes. WWIPL facilitates both buying and selling of unlisted
shares, subject to market demand and availability.
Q: What
documents are required to buy Voxtur Bio shares through WWIPL?
Answer: Investors generally need PAN, Aadhaar, Client Master Report
(CMR), and bank account details to complete the transaction.
Q: What
are the risks of investing in Voxtur Bio shares?
Answer: Investors should consider regulatory approvals, competition in
diagnostics, technology changes, execution risks, and liquidity constraints
associated with unlisted shares.
Q: How
does WWIPL help investors track Voxtur Bio investments?
Answer: WWIPL provides company updates, transaction assistance, market
insights, and investment support to help investors make informed decisions.
Q: How
long does it take for Voxtur Bio shares purchased through WWIPL to be credited
to a Demat account?
Answer: Shares are generally credited to the investor's Demat account
after successful completion and verification of the transaction.
Q: What
should investors evaluate before investing in Voxtur Bio Ltd?
Answer: Investors should assess the company's financial performance,
product portfolio, R&D capabilities, regulatory compliance, profitability,
and long-term growth prospects.
Q: Can
Voxtur Bio benefit from India's growing diagnostics and healthcare sector?
Answer: Yes. Rising healthcare awareness, increasing diagnostic testing,
and growing demand for affordable medical diagnostics may support the company's
long-term growth.